Home    About Us    Medic-All    Bio B2B    Hot Topic     Expo     Login | Join Now          

ON101

ON101

The first botanic drug for diabetic foot ulcer (DFU)

Request for Collaboration
Overview
There are 415 million diabetes patients in the world by 2015 and 10-15% of them have DFU which may lead to amputation or even death.ON101 is the first botanic drug for diabetic foot ulcer (DFU). 
 
  • Target Chronic DFU with Grade 1 or 2 per Wagner Ulcer Classification System
  • Fulfill the Global Unmet Medical Need in DFU
  • Clinical Status: Phase III Interim Analysis (2016)
  • In compliance to US FDA “Guidance for Industry Botanical Drug Product”
Development Plan of ON101
  • US Phase III IND: 79526
  • Taiwan NDA: Expected by 2017
  • China Phase III IND: Expected by Q1 2017
  • EU Phase III IND: Expected by Q1 2017
  • US Phase III IND : Expected by 2017 (Breakthrough Designation)
People who like this also like
  • PHN013 (Orphan drug;ITP)PHN013 (Orphan drug;ITP)
  • The Most Professional AccreditationThe Most Professional Accreditation
  • FLISA (IgE/IgG test)FLISA (IgE/IgG test)
  • TLC177TLC177
  • Analysis Method for Breast Image and Electronic Apparatus ThereofAnalysis Method for Breast Image and Electronic Apparatus Thereof
  • low-alcohol formulation (iLEF) platformlow-alcohol formulation (iLEF) platform
  • Pegylation PlatformPegylation Platform
  • Cancer screening by next generation sequencingCancer screening by next generation sequencing
  • TAH4411 Antiemetic Oral Thin FilmTAH4411 Antiemetic Oral Thin Film
  • Zwitterionic interface processing technologyZwitterionic interface processing technology